Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Nirmatrelvir-ritonavir on Changes in Healthcare Utilization and Frailty Following COVID-19: a Difference-in-difference Analysis

NCT07090486 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07090486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Nirmatrelvir-ritonavir on Changes in Healthcare Utilization and Frailty Following COVID-19: a Difference-in-difference Analysis
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
April 15, 2025
Completion date
April 15, 2025
Enrollment
14,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19